Roivant Sciences Competitors and Similar CompaniesClear all
Roivant Sciences's competitors and similar companies include Horizon Therapeutics, Samumed, SciClone Pharmaceuticals and Sage Therapeutics.
 Horizon Therapeutics Horizon Therapeutics (formerly known as Horizon Pharma) is a biopharmaceutical company focused on researching, developing, and commercializing medicines. |  Samumed Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. |  SciClone Pharmaceuticals SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders. |  Sage Therapeutics Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders. | ||
Founding Date | Founding Date 2014 | Founding Date 2008 | Founding Date 2008 | Founding Date 1989 | Founding Date 2010 |
Type | Type Public | Type Subsidiary | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations London, GB HQ Basel, CH Boston, US New York, US | Locations Dublin, IE HQ | Locations San Diego, US HQ San Diego, US | Locations Foster City, US HQ | Locations Cambridge, US HQ Raleigh, US |
Employees | Employees 908 | Employees 2,662 | Employees 1701% increase | Employees 1102% decrease | Employees 6756% increase |
Valuation ($) | Valuation ($) 8.8 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 517.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) $8.3m (FY, 2025) | Revenue (est.) $3.6b (FY, 2022) | Revenue (est.) N/A | Revenue (est.) $160.1m (FY, 2016) | Revenue (est.) $41.2m (FY, 2024) |
Net income | Net income ($397.9m) (FY, 2025) | Net income $521.5m (FY, 2022) | Net income N/A | Net income $30.7m (FY, 2016) | Net income ($400.7m) (FY, 2024) |
Operating ⚠ | |||||
Phase I Trials Products | Phase I Trials Products 4 (Q2, 2021) | Phase I Trials Products 3 (Sep, 2021) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products 5 (Q2, 2021) | Phase II Trials Products 12 (Sep, 2021) | Phase II Trials Products N/A | Phase II Trials Products N/A | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products 1 (Q2, 2021) | Phase III Trials Products 2 (Sep, 2021) | Phase III Trials Products N/A | Phase III Trials Products N/A | Phase III Trials Products N/A |
Funding | |||||
Total funding raised | Total funding raised $ 1.9b | Total funding raised $ 63m | Total funding raised $ 438m | Total funding raised N/A | Total funding raised $ 93m |
For sources of this data, please see the company profile
View Company Profiles
Horizon Therapeutics
HQ
Dublin, IE
Horizon Therapeutics (formerly known as Horizon Pharma) is a biopharmaceutical company focused on researching, developing, and commercializing medicines.
View companySamumed
HQ
San Diego, US
Employees
170↑ 1% increase
Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation.
View companySciClone Pharmaceuticals
HQ
Foster City, US
Employees
110↓ 2% decrease
SciClone Pharmaceuticals (SciClone) is a global specialty pharmaceutical company with a product portfolio spanning major therapeutic markets including oncology, infectious diseases and cardiovascular disorders.
View companySage Therapeutics
HQ
Cambridge, US
Employees
675↑ 6% increase
Sage Therapeutics is a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.
View company